GGrantIndex
← Search

Task X9: Agilvax Phage Display for Multiple Vaccine Candidates

$8,224N01FY2023AINIH

Advanced Bioscience Laboratories, Inc., Kensington MD

Investigators

Abstract

This contract provides for manufacturing vaccine and biologic products in accordance with relevant cGMP Phase I/II FDA regulations and guidelines under the NIAID Preclinical Services for Manufacturing and Characterization Services Program.

View original record on NIH RePORTER →